ANEB Scorecard | ANEBULO PHARMACEUTICALS, INC.

ANEBULO PHARMACEUTICALS, INC. (ANEB) Scorecard

2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.

40 QUARTERS × 3 ROAST BATTLES

6/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

Quarter	Total return	Revenue growth	EPS growth
2026-Q20/3	LoseANEB / S&P -60.10% / 15.20%	LoseANEB / S&P ANEB unavailable / 15.00%	LoseANEB / S&P ANEB unavailable / 50.40%
2026-Q11/3	WinANEB / S&P -1.98% / -4.33%	LoseANEB / S&P ANEB unavailable / 11.30%	LoseANEB / S&P ANEB unavailable / 27.70%
2025-Q40/3	LoseANEB / S&P -59.60% / 2.65%	LoseANEB / S&P ANEB unavailable / 9.00%	LoseANEB / S&P -32.14% / 13.40%
2025-Q31/3	WinANEB / S&P 73.61% / 8.12%	LoseANEB / S&P ANEB unavailable / 4.61%	LoseANEB / S&P -23.33% / 13.45%
2025-Q20/3	LoseANEB / S&P 10.77% / 10.94%	LoseANEB / S&P ANEB unavailable / 4.83%	LoseANEB / S&P -18.75% / 10.63%
2025-Q10/3	LoseANEB / S&P -22.62% / -4.27%	LoseANEB / S&P ANEB unavailable / 4.98%	LoseANEB / S&P -29.73% / 10.57%
2024-Q40/3	LoseANEB / S&P -12.95% / 2.41%	LoseANEB / S&P ANEB unavailable / 5.25%	LoseANEB / S&P -33.33% / 6.15%
2024-Q30/3	LoseANEB / S&P -29.30% / 5.89%	LoseANEB / S&P ANEB unavailable / 5.89%	LoseANEB / S&P -34.78% / 6.11%
2024-Q20/3	LoseANEB / S&P -4.88% / 4.28%	LoseANEB / S&P ANEB unavailable / 5.38%	LoseANEB / S&P -31.91% / 5.12%
2024-Q11/3	WinANEB / S&P 18.60% / 10.56%	LoseANEB / S&P ANEB unavailable / 5.71%	LoseANEB / S&P ANEB unavailable / 5.59%
2023-Q40/3	LoseANEB / S&P -20.79% / 11.69%	LoseANEB / S&P ANEB unavailable / 6.81%	LoseANEB / S&P ANEB unavailable / 7.78%
2023-Q31/3	WinANEB / S&P 30.00% / -3.27%	LoseANEB / S&P ANEB unavailable / 7.52%	LoseANEB / S&P ANEB unavailable / -5.03%
2023-Q20/3	LoseANEB / S&P -18.97% / 8.74%	LoseANEB / S&P ANEB unavailable / 9.50%	LoseANEB / S&P ANEB unavailable / -8.57%
2023-Q11/3	WinANEB / S&P 19.64% / 7.50%	LoseANEB / S&P ANEB unavailable / 10.77%	LoseANEB / S&P ANEB unavailable / -15.69%
2022-Q40/3	LoseANEB / S&P -13.43% / 7.56%	LoseANEB / S&P ANEB unavailable / 11.88%	LoseANEB / S&P ANEB unavailable / -17.99%
2022-Q30/3	LoseANEB / S&P -46.15% / -4.88%	LoseANEB / S&P ANEB unavailable / 13.47%	LoseANEB / S&P ANEB unavailable / -1.41%
2022-Q20/3	LoseANEB / S&P -26.55% / -16.10%	LoseANEB / S&P ANEB unavailable / 13.71%	LoseANEB / S&P ANEB unavailable / 11.04%
2022-Q11/3	WinANEB / S&P 15.12% / -4.60%	LoseANEB / S&P ANEB unavailable / 15.97%	LoseANEB / S&P ANEB unavailable / 42.23%
2021-Q40/3	LoseANEB / S&P -6.11% / 11.03%	LoseANEB / S&P ANEB unavailable / 15.00%	LoseANEB / S&P ANEB unavailable / 96.40%
2021-Q30/3	LoseANEB / S&P -3.96% / 0.58%	LoseANEB / S&P ANEB unavailable / 10.77%	LoseANEB / S&P ANEB unavailable / 69.42%
2021-Q20/3	LoseANEB / S&P ANEB unavailable / 8.55%	LoseANEB / S&P ANEB unavailable / 6.58%	LoseANEB / S&P ANEB unavailable / 51.81%
2021-Q10/3	LoseANEB / S&P ANEB unavailable / 6.17%	LoseANEB / S&P ANEB unavailable / -1.06%	LoseANEB / S&P ANEB unavailable / 7.39%
2020-Q40/3	LoseANEB / S&P ANEB unavailable / 12.15%	LoseANEB / S&P ANEB unavailable / -3.72%	LoseANEB / S&P ANEB unavailable / -33.42%
2020-Q30/3	LoseANEB / S&P ANEB unavailable / 8.93%	LoseANEB / S&P ANEB unavailable / -2.04%	LoseANEB / S&P ANEB unavailable / -27.10%
2020-Q20/3	LoseANEB / S&P ANEB unavailable / 20.54%	LoseANEB / S&P ANEB unavailable / -0.46%	LoseANEB / S&P ANEB unavailable / -27.11%
2020-Q10/3	LoseANEB / S&P ANEB unavailable / -19.60%	LoseANEB / S&P ANEB unavailable / 3.47%	LoseANEB / S&P ANEB unavailable / -14.75%
2019-Q40/3	LoseANEB / S&P ANEB unavailable / 9.07%	LoseANEB / S&P ANEB unavailable / 5.36%	LoseANEB / S&P ANEB unavailable / 2.99%
2019-Q30/3	LoseANEB / S&P ANEB unavailable / 1.70%	LoseANEB / S&P ANEB unavailable / 5.02%	LoseANEB / S&P ANEB unavailable / 0.21%
2019-Q20/3	LoseANEB / S&P ANEB unavailable / 4.30%	LoseANEB / S&P ANEB unavailable / 6.64%	LoseANEB / S&P ANEB unavailable / 8.65%
2019-Q10/3	LoseANEB / S&P ANEB unavailable / 13.65%	LoseANEB / S&P ANEB unavailable / 8.12%	LoseANEB / S&P ANEB unavailable / 14.29%
2018-Q40/3	LoseANEB / S&P ANEB unavailable / -13.52%	LoseANEB / S&P ANEB unavailable / 9.05%	LoseANEB / S&P ANEB unavailable / 18.23%
2018-Q30/3	LoseANEB / S&P ANEB unavailable / 7.71%	LoseANEB / S&P ANEB unavailable / 10.21%	LoseANEB / S&P ANEB unavailable / 19.06%
2018-Q20/3	LoseANEB / S&P ANEB unavailable / 3.43%	LoseANEB / S&P ANEB unavailable / 9.03%	LoseANEB / S&P ANEB unavailable / 14.46%
2018-Q10/3	LoseANEB / S&P ANEB unavailable / -0.76%	LoseANEB / S&P ANEB unavailable / 7.68%	LoseANEB / S&P ANEB unavailable / 12.46%
2017-Q40/3	LoseANEB / S&P ANEB unavailable / 6.64%	LoseANEB / S&P ANEB unavailable / 7.03%	LoseANEB / S&P ANEB unavailable / 13.82%
2017-Q30/3	LoseANEB / S&P ANEB unavailable / 4.48%	LoseANEB / S&P ANEB unavailable / 5.68%	LoseANEB / S&P ANEB unavailable / 17.57%
2017-Q20/3	LoseANEB / S&P ANEB unavailable / 3.09%	LoseANEB / S&P ANEB unavailable / 4.83%	LoseANEB / S&P ANEB unavailable / 17.74%
2017-Q10/3	LoseANEB / S&P ANEB unavailable / 6.07%	LoseANEB / S&P ANEB unavailable / 3.67%	LoseANEB / S&P ANEB unavailable / 13.32%
2016-Q40/3	LoseANEB / S&P ANEB unavailable / 3.82%	LoseANEB / S&P ANEB unavailable / 2.09%	LoseANEB / S&P ANEB unavailable / 7.05%
2016-Q30/3	LoseANEB / S&P ANEB unavailable / 3.85%	LoseANEB / S&P ANEB unavailable / 0.20%	LoseANEB / S&P ANEB unavailable / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

Metric	ANEB total return	S&P 500 Total Return Index
Total return	-86.80%	20.78%
Annualized return	-86.80%	20.78%

5Y · 2021-09-01 to 2026-08-27

Metric	ANEB total return	S&P 500 Total Return Index
Total return	-95.22%	83.14%
Annualized return	-45.56%	12.86%

10Y · 2021-05-07 to 2026-08-27

Metric	ANEB total return	S&P 500 Total Return Index
Total return	-95.35%	319.30%
Annualized return	-26.43%	15.41%

Calculation rules

window: Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis: Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule: Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency: Quarter endpoints only.
fundamentals: Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
ACTUATE THERAPEUTICS, INC. (ACTU)	United States	$0.015B
Lantern Pharma Inc. (LTRN)	United States	$0.015B	-2.87
Citius Pharmaceuticals, Inc. (CTXR)	United States	$0.016B	-133.06
Tvardi Therapeutics, Inc. (TVRD)	United States	$0.014B
Vyome Holdings, Inc (HIND)	United States	$0.014B	-1.38
Korsana Biosciences, Inc. (CYCN)	United States	$0.016B
BullFrog AI Holdings, Inc. (BFRG)	United States	$0.014B
LISATA THERAPEUTICS, INC. (LSTA)	United States	$0.014B	-2.13
Pasithea Therapeutics Corp. (KTTA)	United States	$0.017B	-0.81
Vistagen Therapeutics, Inc. (VTGN)	United States	$0.013B	-0.14